Telomir Pharmaceuticals Inc - Bathi saben saham sajroning taun lumaku TELO

This daily price chart for Telomir Pharmaceuticals (TELO) on GURU.Markets, where EPS stands at -136.30, reflects the impact of eco-packaging and waste disposal costs. Rising laboratory expenses in the absence of mass production are increasing the cost of longevity research and development. Meanwhile, while Telomir Pharmaceuticals management possesses deep scientific expertise, they currently lack experience in commercializing their discoveries.
Telomir Pharmaceuticals Inc - rincian analitis lan metrik utama (TELO)

This indicator reflects the dynamics of net earnings per share over the last twelve months compared to the same period last year, allowing for an assessment of profit capitalization rates. By analyzing the annual growth of EPS TTM, an investor can see the effectiveness of asset monetization at Telomir Pharmaceuticals (TELO), where the financial result depends directly on the success of preclinical trials and the readiness of capacities for the commercial release of drugs.